Spero Therapeutics, Inc. - Common Stock financial statements
Annual and standalone quarterly facts filed by the company with the SEC. Monetary values are shown in USD millions; per-share values use USD.
Filed statements
| USD; millions except EPS | Jun 2026Filed 12/08/2026 | Mar 2026Filed 13/05/2026 | Sep 2025Filed 13/11/2025 | Jun 2025Filed 12/08/2026 | Mar 2025Filed 13/05/2026 | Sep 2024Filed 13/11/2025 | Jun 2024Filed 12/08/2025 | Mar 2024Filed 13/05/2025 |
|---|---|---|---|---|---|---|---|---|
| $0 | $0 | $0 | $0 | $0 | $0.1 | $0.1 | $0.1 | |
| −$9.6 | −$7.2 | −$7.4 | −$1.7 | −$14 | −$17 | −$18 | −$13 | |
| −$0.16 | −$0.13 | −$0.13 | −$0.03 | −$0.25 | −$0.32 | −$0.33 | −$0.24 | |
| 58 | 57 | 56 | 56 | 55 | 54 | 54 | 54 |
Trend